Winter Seminar: Psychopharmacology: A Master Class
Carl Salzman, MD
The objectives of this class are to provide a review of the mechanisms and an update of the clinical applications of psychotropic drug treatments for psychiatric disorders. The course is directed towards experienced clinicians with a working knowledge of basic psychiatric diagnosis and psychopharmacology treatment.
An updated review of neurobiology and brain function will be presented, taking the attendee through neurotransmission sequence from synthesis to gene transcription. Specific categories of treatment will include treatment of bipolar disorder, depression, anxiety, sleep disorders, borderline personality and eating disorders. Potential new uses for atypical antipsychotic drugs as well as potential new uses for mood stabilizers will be reviewed. The use of antipsychotic drugs in neurologic disorders will be presented. A comprehensive review of depression in psychiatric patients as well as comorbid with medical illnesses will be emphasized along with the use of antidepressants of all treatment classes for comorbid depressions. The role of depression in cardiovascular illness and the necessity for treatment as well as the interaction between endocrine disorders (especially diabetes) and depression will be highlighted. Psychiatric medications for the elderly will be presented. The neurobiological mechanisms of anxiety and anxiety-spectrum disorders as well as their treatment will be reviewed, including obsessive-compulsive disorder, panic disorder, social anxiety disorder, post-traumatic stress disorder (PTSD), and general anxiety disorder. The course will emphasize the establishment and importance of therapeutic alliance when prescribing all psychotropic medications. Educational presentation will be in seminar format and include lectures, participant discussions and Q & A.
- Apply the latest advances in the neurobiology and genetics of psychiatric disorders and their psychopharmacologic therapies;
- Assess and compare current mechanisms and latest treatment of psychotic disorders; schizophrenia and bipolar illness;
- Analyze and assess the neurobiological mechanisms and evidence-based treatment of depressive and anxiety-spectrum disorders;
- Identify the mechanisms and evidence based treatments of addictive disorders;
- Review psychopharmacology issues associated with pregnancy and nursing;
- Describe diagnosis and treatment of eating disorders;
- Discuss the latest advances in geriatric psychopharmacology.
Meets Monday-Friday: 9am-12:15pm
Beth Israel Deaconess Department of Psychiatry Foundation, Inc./Contact Hours: 15
The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Harvard Medical School designates this live activity for a maximum of 15 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.
Psychologists: The Massachusetts School of Professional Psychology (MSPP) is approved by the American Psychological Association to offer continuing education for psychologists. Massachusetts School of Professional Psychology maintains responsibility for this program and its content.
Counselors: The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School is an NBCC-Approved Continuing Education Provider (ACEPTM) and may offer NBCC-approved clock hours for events that meet NBCC requirements. The ACEPTM solely is responsible for all aspects of the program.” The winter seminar programs meet the criteria for 15 clock hours.
Social Workers: Application for social work continuing education credits has been submitted.
Nurses: This activity has been submitted to the Ohio Nurses Association (OBN-001-91 for approval to award contact hours. The Ohio Nurses Association is accredited as an approver of continuing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Educators: Application has been made to Commonwealth of Massachusetts to offer Professional Development Points(PDP’s).
Carl Salzman, MD Professor of Psychiatry, Harvard Medical School. He has served as Chairman, American Psychiatric Association Benzodiazepine Task Force. He has been awarded the Elvin Semrad Award for Outstanding Teaching in Psychiatry at the Massachusetts Mental Health Center. He shared the Vestermark Award from the American Psychiatric Association for Outstanding Contribution to Psychiatric Education. He was awarded the Heinz E. Lehmann Award from the New York State Department of Mental Hygiene for his contribution to psychiatric research. In 2003 Dr. Salzman was nationally recognized with a Teacher of the Year Award. In 2006, he received the Outstanding Educator Award from the Massachusetts Psychiatric Society. He has also been on numerous editorial boards including The American Journal of Psychiatry. Dr. Salzman is the author of over 300 publications and 7 books. His latest book is Clinical Geriatric Psychopharmacology, 4th edition.